RT
Rani Therapeutics Holdings, Inc.
SEC filingBiotechnology · San Jose, CA
Amount raised$60.3Msold at filing
Total offering$60.3M
Investors in the raise15count reported to the SEC
FiledNov 10, 2025first sale Oct 23, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Talat ImranExecutive Officer, Director
Abraham BassanDirector
Vasudev Bailey, M.D.Director
Svai SanfordExecutive Officer
Mir HashimExecutive Officer
Jean-Luc ButelDirector
Lisa RomettyDirector
Mir ImranDirector
Dennis AusielloDirector
Executive officers, directors and promoters as listed on the Form D.